Correlation between detection of anti-viral antibody and histopathological disease activity in an epidemic of hepatitis C
- PMID: 1381909
- DOI: 10.1007/BF01309693
Correlation between detection of anti-viral antibody and histopathological disease activity in an epidemic of hepatitis C
Abstract
There was an epidemic of non-A non-B hepatitis in a small area of a town in the central part of Japan, which began with an outbreak of several patients in 1981 and then spread extensively with the result that about one third of the inhabitants showed abnormality in serum liver function tests at the health check performed in 1985. We determined histological diagnoses on that occasion for 167 individuals of the abnormal population and recently assayed antibodies against hepatitis C virus (HCV) for most of their sera left available. Histologically, chronic active hepatitis (CAH) was the major pattern, accounting for 59.3% (99 cases) of the total. Others were chronic persistent hepatitis (CPH) (13.2%), chronic lobular hepatitis (CLH) (16.2%), liver cirrhosis (LC) (6.6%) and fatty liver (4.8%). In the serological studies, the newly developed system to detect antibodies against the viral core protein p 22 was found to be much more sensitive than the conventional system to detect anti C 100-3 antibodies. By using these two methods in combination, we found that 82% were antibody-positive, indicating strong implication of HCV in this epidemic. This was further supported by direct detection of the viral genome in patients' sera by polymerase chain reaction following reverse transcription. We further found a strong correlation between the histological inflammatory activity and the antibody prevalence, since nearly all (97.6%) of the CAH cases were antibody-positive by at least either of the antibody assays, while only about 50% were positive in the less active cases such as CPH and CLH.
Similar articles
-
Anti-C100-3 antibody status, viral genomic sequences, and clinical features in chronic hepatitic patients with hepatitis C virus RNA in sera.Acta Med Okayama. 1992 Aug;46(4):285-93. doi: 10.18926/AMO/32629. Acta Med Okayama. 1992. PMID: 1332424
-
High rate of mixed genotypes of hepatitis C virus in patients of an epidemic area in Japan.J Gastroenterol Hepatol. 1994 Nov-Dec;9(6):620-3. doi: 10.1111/j.1440-1746.1994.tb01571.x. J Gastroenterol Hepatol. 1994. PMID: 7532450
-
Detection of hepatitis C virus sequences in liver tissue by the polymerase chain reaction.Lab Invest. 1991 Oct;65(4):408-11. Lab Invest. 1991. PMID: 1656140
-
[Serodiagnosis of hepatitis C by a recombinant hepatitis C virus protein].Nihon Rinsho. 1993 Feb;51(2):329-33. Nihon Rinsho. 1993. PMID: 7681883 Review. Japanese.
-
[Hepatitis C virus].Rev Fr Transfus Hemobiol. 1992 Jul;35(3):155-62. doi: 10.1016/s1140-4639(05)80118-2. Rev Fr Transfus Hemobiol. 1992. PMID: 1329790 Review. French.
Cited by
-
Immunosuppressive therapy and hepatitis C virus infection: the clinical course of liver disease.J Mol Med (Berl). 1996 Jul;74(7):407-12. doi: 10.1007/BF00210635. J Mol Med (Berl). 1996. PMID: 8841953
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials